INTRODUCTION
For several years we have studied animals with immediate-type airway responses to inhaled antigens in attempts to provide a model of human asthma suitable for immunologic, pharmacologic, and physiologic studies.
The features of such a model that seemed desirable included the following: The immunologically mediated hypersensitivity should be due to reaginic antibody analogous to human IgE; spontaneous, i.e., due to exReceived for publication 22 September 1975 and in re7ised form 3 November 1975. posure to antigens in the environment rather than a result of laboratory immunization procedures; and of long duration, so that the reactivity was similar to the human disease state and so that the same animal could be studied in repetitive experiments. The animals should be sufficiently large so that pulmonary function studies, bronchial lavage, and other studies could be done with ease and without loss of the animal. Canine and primate models fulfilling these criteria were developed and the characteristics of the responses recently reviewed (1). The canine model had the advantage of availability but usefulness was limited by the marked variability of each animal's response in individual experiments to antigen challenge, even under experimental conditions controlled as carefully as possible. The monkey model, with Macaca mulatta, appeared significantly superior to the canine system in that the airway responses were more consistent in degree of reaction and occurred in primates; thus, they more likely simulate human responses. The major limitation of the rhesus model, which we reported previously, was that the availability of animals with the type of respiratory reactivity required appeared sufficiently limited to inhibit significantly the potential usefulness of this system (1) . We now report the method of establishment of a colony of rhesus monkeys that fulfill the criteria described above, the status of these animals over observation ranging from 1 to 3 yr, and some recent observations comparing animals with persistent airway responses with the nonreactive controls.
We propose that the rhesus monkeys with the respiratory responses described in these experiments constitute the most appropriate model of human asthma currently available. Further, use of the animals as described for these experiments carefully conserves a spe-cies that may become increasingly fewer and less available.
METHODS
Animals. Animals are young adult male and female M. mulata, obtained from Primate Imports Corp., Port Washington, N. Y. Initially, monkeys received for research at this medical center were screened for cutaneous reactivity to ascaris antigen (AA) .' Those animals with marked cutaneous reactivity (positive at a 10-dilution) to ascaris challenge were retained for further study. Subsequently, a cutaneous screening service has been conducted by Primate Imports, Inc. This service has included skin-testing animals to the purified AA and supplying only those animals with cutaneous reactivity, with a positive cutaneous response to challenge with a 10-" dilution of antigen. All animals are considered free of parasitic infestations because all have received treatment with at least two separate courses of thiabendazole. Each animal is housed individually, with standard cage cleaning with wash water at 180'C, limiting possibilities of cross-contamination with parasitic infestations. Fecal examination of selected animals have revealed no evidence of ova or parasites.
Antigens and antisera. AA is a sequential Sephadex (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) G50 and 75 column fraction of Ascaris suum extract prepared by the method of Hogarth-Scott (2). Standardization of each preparation of AA was done both by determination of protein as estimated by optical density at 280 nm (Beckman DU spectrophotometer; Beckman Instruments, Fullerton, Calif.) and cutaneous titration in AA-sensitive animals (3) . The preparation of AA in current use contains 0.8 mg protein/ml and is stored at 4"C in phosphate-buffered 0.15 M NaCl, pH 7.35 (PBS). Rabbit anti-human IgE was prepared against the Fc fragment of IgE myeloma P.S. Such anti-human IgE has been shown to cross-react with rhesus IgE (4). The anti-IgE used in these studies bound 0.828 mg 'I-IgE/ml.
Cutaneous testing. Animals were anesthetized with pentobarbital and received 2.5 ml of 0.5% Evans' blue dye. Intracutaneous tests were performed by injection of 0.1 ml of serial 10-fold dilutions of AA in PBS. The cutaneous titer was recorded as the dilution of antigen producing the last definitive positive bluing reaction, as compared with the control site injected with PBS (3, 5).
Pharmacologic agents. Carbocholine (Car) and histamine (H) were obtained from Sigma Chemical Co., St and changes in pulmonary function subsequent to this challenge were recorded. The methodology for recording changes in pulmonary function has been described in detail recently (6) . Recordings of the following parameters of respiration are made: breathing frequency, peak expiratory flow rate, tidal volume, ratio of expiratory to inspiratory time, pulmonary resistance, and dynamic compliance. In selected experiments, arterial Po0, muscle Po2, or both are recorded by indwelling electrodes with a disposable in vivo oxygen catheter attached to a multipurpose oxygen analyzer (International Biophysics Corp., Irvine, Calif.) (7) . In a large series of experiments, considerable variations were observed in the respiratory function parameters of different animals (6) . Because of this, the most useful experimental system for analysis of the AA response was found to be the comparison of post-challenge results with those obtained during the control period after the PBS challenge, with expression of the results as percent change in pulmonary function from the base-line control period.
Respiratory secretions (RS) and cells. Rhesus monkeys were anesthetized and an endotracheal tube was inserted. A 1.5-mm catheter was passed through the endotracheal tube. 50 ml of lactated Ringer's solution in aliquots of 10 ml were used to lavage thle bronchi with intermittent aspiration of the lavage fluid. The recovered fluid, between 50-75%o of the volume of the lactated Ringer's introduced, was centrifuged and the cells were used for mediator release studies and the supernate was used for the quantitation of selected proteins.
Estimation of rhesus serum(S) and RS proteins. The RS was concentrated by means of a diaflo ultrafiltration membrane XM 50 with a 10 PA Propellent Cell (Amicon Corp., Lexington, Mass.). The concentrations of albumin and IgG were estimated by means of radial immunodiffusion plates prepared for quantitation of human serum albumin and IgG (Behring Diagnostics, American Hoechst Corp., Sommerville, N. J.). IgE concentration was determined by the double-antibody radioimmunoassay of Gleich et al. (8) . This inhibition assay, developed for measurement of human IgE, expresses IgE as units and 1 U approximates 2.4 ng of IgE. The use of these assays for human serum proteins for quantitative estimation of the rhesus monkey serum proteins is based on the cross-reactivity of antiserum against human serum proteins with the analogous serum proteins from other primates. For example, the cross-reactivity of monkey IgE with antiserum against human IgE was established by Ishizaka and Ishizaka (9) . In this laboratory, experiments conducted with monkey serum albumin (a Sephadex G200 peak III preparation of rhesus serum), monkey IgG (a diethylaminoethyl peak I preparation of rhesus serum) (DEAE reference), and IgE (with whole monkey reaginic serum) indicated at least 70% cross-reactivity between these rhesus monkey serum proteins and the analogous human serum proteins with the antiserum currently in use against human serum proteins. In these experiments, the concentrations of rhesus albumin, IgG, and IgE are compared only with the concentrations of these proteins from different animals or different body fluids of the same animals. The results are expressed as milligrams per milliliter for albumin and IgG and units per milliliter for IgE, with the clear Peripheral blood leukocyte (PBL) and respiratory cell (RC) histamine release. These studies were done as previously described (10 
RESULTS
Current status of the monkey colony. The total population of the monkey colony is 12 animals. 10 of these animals were selected for the colony because of the presence of positive cutaneous reactivity to dilutions of 10O or greater of AA. Two animals with negative cutaneous reactivity to undiluted AA were retained as subjects with negative skin reactivity. The respiratory reactivity of the reactive animals is as follows: Six animals are classified as consistent respiratory reactors (RR) to aerosol challenge. Current criteria for a positive respiratory response are summarized in Table I and an example of a positive response is shown in Fig. 1 (Table III and Fig. 2) . cantly higher IgE/Alb ratio demonstrated in pared with S indicates that the IgE is a s in the lower (subglottic) respiratory tract in and that IgG is not.
H release phenomena. The release of H and RC due to two immunologic stimuli (at AA) in the two groups of animals was comi termine whether or not differences betwe4 groups could be demonstrated. The potenti, of DsO on the release of H was also studio sults of H release from PBL and RC due are shown in Fig. 3 . Significant H release 15%) occurred from PBL from every ani nti-lgE and although D20 was necessary to demonstrate a significant Pared to de-release in most samples (Fig. 3) . The potentiating efen the two fect of D20 on H release from PBL is evident. Signifiating effect cant H release from RC due to anti-IgE occurred with ed. The re-cells from all animals except two, and no significant to anti-IgE potentiating effect of D20 is seen (Fig. 3) . No differ-(more than ence in the degree of H release from either PBL or RC imal tested, from the two groups of monkeys RR and NR was observed in these studies with anti-IgE as the immunologic stimulus. The results of H release studies due to AA are shown in Fig. 4 . Significant H release occurred from PBL with or without D20 in all but two experiments (Fig. 4) . These two negative experiments used cells from the two animals with no skin reactivity to AA. The release of H from PBL, when it occurred, was potentiated by D20. Except for these two animals with negative skin reactivity to AA, the RR group could not be distinguished from the NR group by the degree of H release either with or without D20 (Fig. 4) .
H release occurred from some RC after exposure to AA (Fig. 4) . The release was less than that from PBL of the same animal (Fig. 4) . Potentiation of RC H release occurred with D20, but this potentiation is less than with PBL from the same animal. The H release 0 studies show a difference between the RR and the NR, in that no evidence of H release due to AA, either with c >°o or without D20, was demonstrated in the NR group, whether they were positive or negative skin reactors. Fig. 1) , prostaglandin F., or H (12). The RR and NR groups of animals (Table II) were tested with 15 inhalations of increasing concentrations of Car (0.1 mg, 0.25, 2.5, and 10 mg/ml). The concentration of Car that gave a definitive respiratory response was determined. An example of a recording of respiratory function of such an experiment is shown in Fig. 5 . This demonstrates a positive respiratory response to a concentration of 2.5 mg Car/ml. All animals in Table II were tested identically to determine the threshold concentration of Car giving a positive response. The criteria for a positive respiratory response to aerosolization of Car were those described above for determination of a positive respiratory response to antigen challenge ( Table I ). The lowest concentrations of Car to which animals in Table II The results of studies of the proteins obtained by bronchial lavage of monkeys in these studies are similar to those obtained by bronchial lavage of human lungs (13) . In volunteer nonsmoking human subjects, the ratios of IgG to Alb were 0.12±0.02 (mean+SEM of combined ratios) in bronchial fluid and 0.23±0.02 in serum (13) . These ratios were of similar magnitude in the bronchial fluid and serum of the rhesus monkeys (13) . The marked differences in IgE to Alb and IgG to Alb ratios seen in S and RS are consistent with IgE being a secretory Ig in the lower (subglottic) respiratory tract in rhesus monkeys, an observation suggested for humans by Ishizaka and Newcomb (14) . (Table IV) . The hyperresponsiveness of the human asthmatic to analogues of acetylcholine is well known (15, 16) , and the current results in the RR group of rhesus monkeys may constitute a related finding in this primate model. Thus, in the rhesus model of asthma we describe here, the Prevous studies of H release from rhesus RC did not demonstrate significant potentiation of AA-induced H release by D20 (10) . The current studies (Fig. 4) suggest that the RR group has both H release from RC due to AA and potentiation of H release due to DsO . The failure to demonstrate this previously was because the majority of cell studies utilized animals with cutaneous but not respiratory responses.
The current studies of the RR and NR group demonstrated that the only differences detectable between the two groups were the Car sensitivity and H release from RC due to AA (but not of anti-IgE) of the RR groups. We have previously shown a potentiating relationship between the cholinergic stimulation of Car, the immunologic stimulation of antigen, and the pharmacologic stimulation of H (12) . Although these interactions are complex, study of the autonomic, immunologic, and pharmacologic interactions may help determine why some animals are consistent respiratory responders and others are not.
